Diverse Companies with Specialized Areas of Expertise

Teikoku Pharma USA, Inc

The overseas expansion base, located in the heart of Silicon Valley, boasts extensive expertise in global drug development and a proven track record of approval. 

TPU possesses transdermal formulation expertise, and a highly experienced clinical and regulatory team. Moreover, in collaboration with our worldwide partners, TPU distributes products to key markets globally. Mirroring Teikoku Seiyaku’s reputation, TPU excels not only in topical external preparations such as hydrogels, tapes, and ointments but also in systemic transdermal patches, solidifying its position as industry experts.

Homepage

Headquarters

1718 Ringwood Avenue, San Jose, CA95131 USA
TEL +1-408-501-1800　
FAX +1-408-501-1900

---

Teikoku Pharmacare Co., Ltd.

Responsible for domestic marketing of non-prescription medicines, cosmetics, and other products.

Teikoku Pharmacare was established in 1995 through the merger of Teikoku Seiyaku’s non-prescription drug division and Teikoku Medix’s OTC division. Teikoku Pharmacare provides extensive services to pharmacies, drugstores, and judo therapists through sales activities of its own products as well as products for chain stores, and products for the judo therapy market.

Homepage

---

Teikoku Kampo Seiyaku Co., Ltd.

Responsible for the manufacture and sale of Chinese herbal extracts.

Teikoku Kampo Seiyaku was established in 1985 as the kampo drug manufacturing division of Teikoku Seiyaku.
The laboratory is located in Awa City, Tokushima Prefecture, and currently collects and responds to information on side effects and quality of distributed products.

Homepage

---

Seren Pharmaceuticals Inc.

SEREN is an expert group that speedily develops drug candidates which are experiencing drug time lag and which meet the medical requirements of patients.

SEREN was established in 2010 as a clinical development specialized pharmaceutical company. SEREN searches for new drug candidates that have been validated for efficacy and safety, but that have not been developed despite established medical needs. SEREN obtains rights which are for development, manufacturing and marketing of these candidates from the licensors. It proceeds with their development efficiently in a short period of time and promptly commercializes them.
EREN will continue to respond to unmet medical needs and promote the acquisition and early development of drugs that are desired to be developed.

Homepage